Genmab News Date Title View News Category Articles of AssociationCompany AnnouncementsMedia Releases Year None2020201920182017201620152014201320122011201020092008200720062005200420032002 Feb 21, 2020 Genmab Board of Directors Chairman to Step Down 210220_CA06_Board of Directors Feb 19, 2020 Genmab Publishes 2019 Annual Report 05_Genmab_AR19_190220 Jan 23, 2020 Horizon Therapeutics Secures U.S. FDA Approval for Teprotumumab, for the Treatment of Thyroid Eye Disease (TED) 200123_i02_Teprotumumab US Approval Jan 22, 2020 Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen 220120_CA04_DARZALEX FY 19 Sales_Milestone Jan 20, 2020 Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma 200120_CA03_CASSIOPEIA EU Approval Jan 06, 2020 Genmab to Present at the 38th Annual J.P. Morgan Healthcare Conference 200106_i01_JPM Jan 02, 2020 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons 200102_CA_02_Managerial Employees Transactions Jan 02, 2020 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons 200102_CA_01_Managerial Employee Transactions
